• Nem Talált Eredményt

HEALTH STATUS OF YOUNG ADULTS BORN WITH A LOW BIRTH WEIGHT: INVESTIGATION OF THE ASSOCIATION BETWEEN ADRENAL

HWE p érték

8. HEALTH STATUS OF YOUNG ADULTS BORN WITH A LOW BIRTH WEIGHT: INVESTIGATION OF THE ASSOCIATION BETWEEN ADRENAL

FUNCTION, CARBOHYDRATE AND BONE HOMEOSTASIS

SUMMARY

Young adults born with a low birth weight (LBW) present a population characterized by altered adrenal function, slight disturbances of glucose homeostasis and accelerated bone turnover. These specific features provide an opportunity to investigate the interactions between adrenal function, insulin regulation and bone homeostasis. During my PhD work I analyzed bone homeostasis parameters (e.g. bone mineral density (BMD), serum osteocalcin (OC), urinary deoxypyridinoline (DPD) excretion), adrenal function (dehidroepiandrosterone-sulphate (DHEAS), cortisol), sex steroid levels (estradiol, testosterone, and sex-hormone binding globulin (SHBG)) along with insulin, DHEA(S) and cortisol response during an oral glucose tolerance test (OGTT) in healthy 19-21 years old people born with normal or low borth weight.

These results suggest that bone turnover depends on the subjects' birth weight and DHEAS levels. The effect of DHEAS on bone turnover is gender dependent. DHEAS increases bone turnover in fertile women, while it decreases this in men. Reactive hyperinsulinemia during OGTT might activate the androgen pathway of adrenal cortex including DHEA production. Therefore acute hyperinsulinemia might counterbalance to some extent the diurnal decrease of DHEA during OGTT.

In an independent study I reanalyzed genotype distributions in 134 papers published between 1998 and 2003 on biallelic genetic variants in the journal of Atherosclerosis.

69 per cent of authors stated that they had performed Hardy-Weinberg equilibrium (HWE) calculations. The distribution of 45 genotypes from 36 papers did not fulfilled HWE criteria. The authors declared the deviation just in 8 cases (6 papers); 30 papers did not mention this fact. This observations warns the interested readers to be cautious when relying to published genetic results and to perform controlling steps to check previous publications

.

56 9. IRODALOMJEGYZÉK

Abuzeid AM, Hawe E, Humphries SE, Talmud PJ (2003) HIFMECH Study Group.

Association between the Ala379Val variant of the lipoprotein associated phospholipase A2 and risk of myocardial infarction in the north and south of Europe. Atherosclerosis 168:283-288.

Antoniades L, MacGregor AJ, Andrew T, Spector TD (2003) Association of birth weight with osteoporosis and osteoarthritis in adult twins. Rheumatology (Oxford).

42:791-6.

Bardóczy Z, Györffy B, Kocsis I, Vásárhelyi B (2004) Re-calculated Hardy-Weinberg values in papers published in Atherosclerosis between 1995 and 2003. Atherosclerosis.

173:141-143.

Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS (1993) Fetal nutrition and cardiovascular disease in adult life. Lancet 341: 938–941.

Barrett-Connor E, Goodman-Gruen D (1995) Dehydroepiandrosterone-sulphate does not predict cardiovascular death in postmenopausal women. The Rancho Bernardo Study. Circulation 91:1757–1760

Barrett-Connor E, Goodman-Gruen D (1995) The epidemiology of DHEAS and cardiovascular disease. Ann N Y Acad Sci 774:259–270

Beneton MN, Yates AJ, Rogers S, McCloskey EV, Kanis JA (1991) Stanozolol stimulates remodelling of trabecular bone and net formation of bone at the adrenocortical surface. Clin Sci 81:543–549

Biros E, Karan M, Golledge J (2008) Genetic variation and atherosclerosis Current Genomics 29: 29-42

Bodrogi L, Fehér T (1980) Radioimmunológiai (RIA) módszer tesztoszteron

meghatározására emberi vérből, magzatvízből és testszövetekből. Izotóptechnika. 23:

175-181.

Bodrogi L, Fehér T, Korányi L (1981) Radioimmunológiai (RIA) módszer a 17-hidroxi-progeszteron mennyiségének mérésére emberi vérből, magzatvízből és testszövetekből. Kísérletes Orvostudomány. 33: 667-671.

57

Bonofiglio D, Garofalo C, Catalano S, Marsico S, Aquila S, Ando S (2004) Low calcium intake is associated with decreased adrenal androgens and reduced bone age in premenarcheal girls in the last pubertal stages. J Bone Miner Metab 22:64–70

Boonstra VH, Mulder PG, de Jong FH, Hokken-Koelega AC (2004) Serum

dehydroepiandrosterone sulfate levels and pubarche in short children born small for gestational age before and during growth hormone treatment. J Clin Endocrinol Metab.

89:712-717.

Brennan SL, Pasco JA, Urquhart DM, Oldenburg B, Wang Y, Wluka AE (2011) Association between socioeconomic status and bone mineral density in adults: a systematic review. Osteoporos Int. 22:517-27.

Brousseau ME, Bodzioch M, Schaefer EJ, Goldkamp AL, Kielar D, Probst M, Ordovas JM, Aslanidis C, Lackner KJ, Bloomfield Rubins H, Collins D, Robins SJ, Wilson PW, Schmitz G (2001) Common variants in the gene encoding ATP-binding cassette transporter 1 in men with low HDL cholesterol levels and coronary heart disease. Atherosclerosis. 154:607-611

Brunton PJ, Sullivan KM, Kerrigan D, Russell JA, Seckl JR és Drake AJ (2013) Sex-specific effects of prenatal stress on glucose homoeostasis and peripheral metabolism in rats. Journal of Endocrinology 217 161–173

Brunton PJ (2013) Effects of maternal exposure to social stress during pregnancy:

consequences for mother and offspring Reproduction. 146:175-189

Buyalos RP, Bradley EL Jr, Judd HL, Zacur HA, Azziz R (1991) No acute effect of physiological insulin increase on dehydroepiandrosterone sulfate in women with obesity and/or polycystic ovarian disease. Fertil Steril. 56:1179-1182.

Buyalos RP, Geffner ME, Azziz R, Judd HL (1997) Impact of overnight dexamethasone suppression on the adrenal androgen response to an oral glucose tolerance test in women with and without polycystic ovary syndrome. Hum Reprod.

12:1138-1141.

Calkins K, Devaskar SU (2011) Fetal origins of adult disease. Curr Probl Pediatr Adolesc Health Care. 41:158-176

58

Carani C, Qin K, Simoni M, Faustini-Fustini M, Serpente S, Boyd J, Korach KS, Simpson ER (1997) Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med 337:91–95

Chang YT, Zhang L, Alkaddour HS, Mason JI, Lin K, Yang X, Garibaldi LR, Bourdony CJ, Dolan LM, Donaldson DL (1995) Absence of molecular defect in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene in premature pubarche children and hirsute female patients with moderately decreased adrenal 3 beta-HSD activity. Pediatr Res 37:820-824

Clark PM (1998) Programming of the hypothalamo–pituitary–adrenal axis and the fetal origins of adult disease hypothesis. Eur J Pediatr 157: S7–S10.

Conway GS, Jacobs HS, Holly JM, Wass JA (1990) Effects of luteinizing hormone, insulin, insulin-like growth factor-I and insulin-like growth factor small binding protein 1 in the polycystic ovary syndrome. Clin Endocrinol (Oxf). 33:593-603.

Cooper C, Cawley M, Bhalla A, Egger P, Ring F, Morton L, Barker D (1995) Childhood growth, physical activity and peak bone mass in women. J Bone Miner Res 10:940–947

Cooper C, Fall C, Egger P, Hobbs R, Eastell R, Barker D (1997) Growth in infancy and bone mass in later life. Ann Rheum Dis 56:717–721

Cooper C, Westlake S, Harvey N, Javaid K, Dennison E, Hanson M (2006) Review:

developmental origins of osteoporotic fracture. Osteoporos Int. 17:337-347.

Cormier C, Souberbielle JC, Kahan A (2001) DHEA in bone and joint diseases. Joint Bone Spine 68:588-594.

Crandall CJ, Merkin SS, Seeman TE, Greendale GA, Binkley N, Karlamangla AS (2012) Socioeconomic status over the life-course and adult bone mineral density: The Midlife in the U.S. Study Bone 51(1): 107–113.

Dahlgren J, Boguszewski M, Rosberg S, Albertsson-Wikland K (1998) Adrenal steroid hormones in short children born small for gestational age. Clin Endocrinol (Oxf).

49:353-61.

Davis SR, Panjari M, Stanczyk FZ (2011) Clinical review: DHEA replacement for postmenopausal women. J Clin Endocrinol Metab. 96:1642-53.

59

Dennison E, Hindmarsh P, Fall C, Kellingray S, Barker D, Phillips D, Cooper C (1999) Profiles of endogenous circulating cortisol and bone mineral density in healthy elderly men. J Clin Endocrinol Metab 84:3058–3063

Diamond MP, Grainger DA, Laudano AJ, Starick-Zych K, DeFronzo RA (1991) Effect of acute physiological elevations of insulin on circulating androgen levels in nonobese women. J Clin Endocrinol Metab. 72:883-887.

Ebeling P, Koivisto VA (1994) Physiological importance of dehidroepiandroszteron.

Lancet 343:1479–1481

Edwards CR, Benediktsson R, Lindsay RS, Seckl JR (1993) Dysfunction of placental glucocorticoid barrier: Link between fetal environment and adult hypertension? Lancet 341: 355–357.

Ehrmann DA, Barnes RB, Rosenfield RL (1995) Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion.

Endocr Rev. 16:322-353.

Elraiyah T, Sonbol MB, Wang Z, Khairalseed T, Asi N, Undavalli C, Nabhan M, Altayar O, Prokop L, Montori VM, Murad MH (2014) Clinical review: The benefits and harms of systemic dehydroepiandrosterone (DHEA) in postmenopausal women with normal adrenal function: a systematic review and meta-analysis. J Clin Endocrinol Metab 99(10):3536-42.

Eriksson J, Forsén T, Tuomilehto J, Osmond C, Barker D (2000) Fetal and childhood growth and hypertension in adult life. Hypertension 36:790-794.

Excoffier L, Laval G, Schneider S (2007) Arlequin (version 3.0): an integrated software package for population genetics data analysis Evolutionary bioinformatics online Evol Bioinform Online 23;1:47-50.

Falcone T, Finegood DT, Fantus IG, Morris D (1990) Androgen response to endogenous insulin secretion during the frequently sampled intravenous glucose tolerance test in normal and hyperandrogenic women. J Clin Endocrinol Metab.

71:1653-1657.

Farah MJ, Givens JR, Kitabchi AE (1990) Bimodal correlation between the circulating insulin level and the production rate of dehydroepiandrosterone: positive correlation in

60

controls and negative correlation in the polycystic ovary syndrome with acanthosis nigricans. J Clin Endocrinol Metab 70:1075-81.

Fehér T, Bodrogi L (1982) A comparative study of steroid concentrations in human adipose tissue and the peripheral circulation. Clin Chim Acta;126:135-141.

Ferrières J, Ruidavets JB, Fauvel J, Perret B, Taraszkiewicz D, Fourcade J, Niéto M, Chap H, Puel J (1999) Angiotensin I-converting enzyme gene polymorphism in a low-risk European population for coronary artery disease. Atherosclerosis 142:211-216.

Fewtrell MS, Cole TJ, Bishop NJ, Lucas A (2000) Neonatal factors predicting childhood height in preterm infants: evidence for a persisting effect of early metabolic bone disease? J Pediatr 137:668–673

Fewtrell MS, Prentice A, Jones SC, Bishop NJ, Stirling D, Buffenstein R, Lunt M, Cole TJ, Lucas A (1999) Bone mineralization and turnover in preterm infants at 8–12 years of age: the effect of early diet. J Bone Miner Res 14:810–820

Fowkes FG, Lee AJ, Hau CM, Cooke A, Connor JM, Lowe GD (2000) Methylene tetrahydrofolate reductase (MTHFR) and nitric oxide synthase (ecNOS) genes and risks of peripheral arterial disease and coronary heart disease: Edinburgh Artery Study.

Atherosclerosis 150:179-185.

Francois I, de Zegher F (1997) Adrenarche and fetal growth. Pediatr Res. 41:440-442.

Friedlander Y, Leitersdorf E, Vecsler R, Funke H, Kark J (2000) The contribution of candidate genes to the response of plasma lipids and lipoproteins to dietary challenge.

Atherosclerosis 152:239-248.

Frost M, Petersen I, Andersen TL, Langdahl BL, Buhl T, Christiansen L, Brixen K, Christensen K (2013) Birth weight and adult bone metabolism are unrelated: results from birth weight-discordant monozygotic twins. J Bone Miner Res 28:2561-9

Galinsky D, Tysoe C, Brayne CE, Easton DF, Huppert FA, Dening TR, Paykel ES, Rubinsztein DC (1997) Analysis of the apo E/apo C-I, angiotensin converting enzyme and methylenetetrahydrofolate reductase genes as candidates affecting human longevity.

Atherosclerosis 129:177-183.

Gardemann A, Stricker J, Humme J, Nguyen QD, Katz N, Philipp M, Tillmanns H, Hehrlein FW, Haberbosch W (1999) Angiotensinogen T174M and M235T gene

61

polymorphisms are associated with the extent of coronary atherosclerosis.

Atherosclerosis 145:309-314.

Garnero P, Sornay-Rendu E, Claustrat B, Delmas P (2000) Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res 15:1526–1536

Gillberg P, Johansson AG, Ljunghall S (1999) Decreased estradiol levels and free androgen index and elevated sex hormone-binding globulin levels in male idiopathic osteoporosis. Calcif Tissue Int 64:209–213

Gordon CM, Grace E, Jean-Emans S, Goodman E, Crawford MH, Leboff MS (1999) Changes in bone turnover markers and menstrual function after short-term oral DHEA in young women with anorexia nervosa. J Bone Miner Res 14:136–145

Gugl A, Renner W, Seinost G, Brodmann M, Pabst E, Wascher TC, Paulweber B, Iglseder B, Pilger E (2003) Two polymorphisms in the fracalkine receptor CX3CR1 are not associated with peripheral arterial disease. Atherosclerosis 166:339-343.

Guo SW, Thompson EA (1992) Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 48:361-372.

Győrffy B (2004) A D-vitamin receptor génpolimorfizmusainak jelentősége krónikus betegségek kialakulásában, Semmelweis Egyetem, PhD értekezés, Budapest

Györffy B, Kocsis I, Vásárhelyi B (2004) Biallelic genotype distributions in papers published in Gut between 1998 and 2003: altered conclusions after recalculating the Hardy-Weinberg equilibrium. Gut. 53:614-5

Györffy B, Kocsis I, Vásárhelyi B (2004) Missed calculations and new conclusions:

re-calculation of genotype distribution data published in Journal of Investigative Dermatology, 1998-2003. J Invest Dermatol 122:644-6.

Hales CN, Barker DJ (1992) Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 35:595-601.

Hattersley AT, Tooke JE (1999) The fetal insulin hypothesis: An alternative explanation of the association of low birthweight with diabetes and vascular disease.

Lancet 353: 1789–1792.

62

Hattersley AT, McCarthy MI (2005) What makes a good genetic association study?

Lancet 366: 1315-1323.

Hedrick PW, Thomson G (1983) Evidence for balancing selection at HLA. Genetics 104(3):449-56

Hegele RA, Wang J, Harris SB, Brunt JH, Young TK, Hanley AJ, Zinman B, Connelly PW, Anderson CM (2001) Variable association between genetic variation in the CYP7 gene promoter and plasma lipoproteins in three Canadian populations. Atherosclerosis 154:579-587.

Herrmann SM, Blanc H, Poirier O, Arveiler D, Luc G, Evans A, Marques-Vidal P, Bard JM, Cambien F (1996) The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM Study. Atherosclerosis 126:299-303.

Holló I, Fehér T, Szücs J (1970) Serum dehydroepiandrosterone, androsterone and cortisol level in primary postmenopausal and other type osteoporosis. Acta Med Acad Sci Hung. 27:155-60.

Horinek A, Vrablik M, Ceska R, Adamkova V, Poledne R, Hubacek JA (2003) T-1131-->C polymorphism within the apolipoprotein AV gene in hypertriglyceridemic individuals. Atherosclerosis 167:369-370.

Hovi P, Andersson S, Järvenpää AL, Eriksson JG, Strang-Karlsson S, Kajantie E, Mäkitie O (2009) Decreased bone mineral density in adults born with very low birth weight: a cohort study. PLoS Med. 10.1371/journal.pmed.1000135. Epub 2009 Aug 25.

Hoy A, Leininger-Muller B, Poirier O, Siest G, Gautier M, Elbaz A, Amarenco P, Visvikis S (2003) Myeloperoxidase polymorphisms in brain infarction. Association with infarct size and functional outcome. Atherosclerosis 167:223-230.

Hubert GD, Schriock ED, Givens JR, Buster JE (1991) Suppression of circulating delta 4-androstenedione and dehydroepiandrosterone sulfate during oral glucose tolerance test in normal females. J Clin Endocrinol Metab 73:781-784.

Humphries SE, Luong LA, Talmud P.J. Frick MH, Kesäniemi YA, Pasternack A, Taskinen MR, Syvänne M (1998) The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined

63

coronary artery disease in men in the LosteocalcinAT gemfibrozil study. Lopid Coronary Angiography Trial. Atherosclerosis 139:49-56.

Ibanez L, de Zegher F, Potau N (1998) Premature pubarche, ovarian hyperandrogenism, hyperinsulinism and the polycystic ovary syndrome: from a complex constellation to a simple sequence of prenatal onset. J Endocrinol Invest.

21:558-66.

Ibanez L, Lopez-Bermejo A, Díaz M, Suárez L, de Zegher F (2009) Low-birth weight children develop lower sex hormone binding globulin and higher dehydroepiandrosterone sulfate levels and aggravate their visceral adiposity and hypoadiponectinemia between six and eight years of age. J Clin Endocrinol Metab.

94:3696-3699.

Ibanez L, Potau N, Marcos MV, de Zegher F (1999) Exaggerated adrenarche and hyperinsulinism in adolescent girls born small for gestational age. J Clin Endocrinol Metab 84:4739–4741

Ivandić A, Prpić-Krizevac I, Jakić M, Bacun T (1999) Changes in sex hormones during an oral glucose tolerance test in healthy premenopausal women. Fertil Steril 71:268-273.

Ivandić A, Prpić-Krizevac I, Sucić M, Jurić M (1998) Hyperinsulinemia and sex hormones in healthy premenopausal women: relative contribution of obesity, obesity type, and duration of obesity. Metabolism 47:13-19.

Iwai N, Shimoike H, Nakamura Y, Tamaki S, Kinoshita M (1998) The 4G/5G polymorphism of the plasminogen activator inhibitor gene is associated with the time course of progression to acute coronary syndromes. Atherosclerosis 136:109-114.

Jaddoe VW, Witteman JC (2006) Hypotheses on the fetal origins of adult diseases:

contributions of epidemiological studies. Eur J Epidemiol 21:91-102.

Kee F, Amouyel P, Fumeron F. Arveiler D, Cambou JP, Evans A, Cambien F, Fruchart JC, Ducimetière P, Dallongeville J (1999) Lack of association between genetic variations of apo A-I-C-III-A-IV gene cluster and myocardial infarction in a sample of European male: ECTIM study. Atherosclerosis 145:187-195.

64

Kocsis I, Györffy B, Németh E, Vásárhelyi B (2004) Examination of Hardy-Weinberg equilibrium in papers of Kidney International: an underused tool. Kidney Int 65:1956-1958.

Kocsis I, Vásárhelyi B, Györffy A, Györffy B (2004) Reanalysis of genotype distributions published in "Neurology" between 1999 and 2002. Neurology 63:357-358.

Labrie F, Diamond P, Cusan L, Gomez JL, Belanger A, Candas B (1997) Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women. J Clin Endocrinol Metab 82:3498–3505

Lavallée B, Provost PR, Kahwash Z, Nestler JE, Bélanger A (1997) Effect of insulin on serum levels of dehydroepiandrosterone metabolites in men. Clin Endocrinol (Oxf).

46:93-100.

Lindsay RS, Dabelea D, Roumain J, Hanson RL, Bennett PH, Knowler WC (2000) Type 2 diabetes and low birth weight: the role of paternal inheritance in the association of low birth weight and diabetes. Diabetes 49: 445–449.

Mackness B, Mackness MI, Arrol S, Turkie W, Julier K, Abuasha B, Miller JE, Boulton AJ, Durrington PN (1998) Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus. Atherosclerosis 139:341-349.

Martikainen H, Salmela P, Nuojua-Huttunen S, Perälä J, Leinonen S, Knip M, Ruokonen H (1996) Adrenal steroidogenesis is related to insulin in hyperandrogenic women. Fertil Steril. 66:564-570.

McTernan CL, Draper N, Nicholson H, Chalder SM, Driver P, Hewison M, Kilby MD, Stewart PM (2001) Reduced placental 11beta-hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: an analysis of possible mechanisms. J Clin Endocrinol Metab 86:4979-4983.

Meuwese CL, Euser AM, Ballieux BE, van Vliet HA, Finken MJ, Walther FJ, Dekker FW, Wit JM (2010) Growth-restricted preterm newborns are predisposed to functional adrenal hyperandrogenism in adult life. Eur J Endocrinol 163:681-9.

Moghetti P, Castello R, Negri C, Tosi F, Spiazzi G, Brun E, Balducci R, Toscano V, Muggeo M (1996) Insulin infusion amplifies 17 alpha-hydroxycorticosteroid

65

intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20-lyase activity. J Clin Endocrinol Metab 81:881-886.

Morales AJ, Haubrich RH, Hwang JY, Asakura H, Yen SS (1998) The effect of six months treatment with a 100-mg daily dose of dehydroepiandrosterone DHEA on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin Endocrinol (Oxf) 49:421–432

Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K (1995) Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 80:3689–3698

Nawata H, Tanaka S, Tanaka S, Takayanagi R, Sakai Y, Yanase T, Ikuyama S, Haji M (1995) Aromatase in bone cells: association with osteoporosis in postmenopausal women. J Steroid Biochem Mol Biol 53:165–174

Németh E, Vásárhelyi B, Györffy B, Kocsis I (2004) Unreported deviations of genotype distributions from Hardy-Weinberg equilibrium in articles published in Critical Care Medicine between 1999 and 2003. Crit Care Med. 32:1431-3.

Nestler JE, Clore JN, Strauss JF, Blackard WG (1987) The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans. J Clin Endocrinol Metab 64:180-184.

Nielsen DM, Ehm MG, Weir BS (1998) Detecting marker-disease association by testing for Hardy-Weinberg disequilibrium at a marker locus. Am J Hum Genet 63:1531-1540.

Nozaki M, Hashimoto K, Nakano H (2004) Relationship between bone resorption and adrenal sex steroids and their derivatives in oophorectomized women. Fertil Steril 82:1556–1560

66

Ou T, Yamakawa-Kobayashi K, Arinami T, Amemiya H, Fujiwara H, Kawata K, Saito M, Kikuchi S, Noguchi Y, Sugishita Y, Hamaguchi H (1998)

Methylenetetrahydrofolate reductase and apolipoprotein E polymorphisms are independent risk factors for coronary heart disease in Japanese: a case-control study.

Atherosclerosis 137:23-28.

Paolisso G, Tagliamonte MR, Rizzo MR, Giugliano D (1999) Advancing age and insulin resistance: new facts about an ancient history. Eur J Clin Invest 29:758-769.

Pell JP, Smith GC, Walsh D. (2004) Pregnancy complications and subsequent maternal cerebrovascular events: A retrospective cohort study of 119,668 births. Am J Epidemiol 159: 336–342.

Phillips DI, Barker DI, Fall CH, Seckl JR, Whorwood CB Wood PI, Walker BR.

(1998) Elevated plasma cortisol concentrations: a link between low birth weight and the insulin resistance syndrome? J Clin Endocrinol Metab 83:757–760

Poulsen P, Vaag A (2001) Glucose and insulin metabolism in twins: influence of zygosity and birth weight. Twin Res 4:350-355.

Renner W, Pabst E, Paulweber B, Malaimare L, Iglseder B, Wascher TC, Pilger E (2002) The angiotensin-converting-enzyme insertion/deletion polymorphism is not a risk factor for peripheral arterial disease. Atherosclerosis 165:175-178.

Rigó J Jr, Boze T, Derzsy Z, Derzbach L, Treszl A, Lázár L, Sobel G, Vásárhelyi B (2006) Family history of early-onset cardiovascular disorders is associated with a higher risk of severe preeclampsia. Eur J Obstet Gynecol Reprod Biol 128:148-151.

Rogerson FM, Kayes KM, White PC. (1997) Variation in placental type 2 11beta-hydroxisteroid dehydrogenase activity is not related to birth weight or placental weight.

Mol Cell Endocrinol 128:103–109.

Schoof E, Girstl M, Frobenius W, Kirschbaum M, Dörr HG, Rascher W, Dötsch J (2001) Decreased gene expression of 11beta-hydroxisteroid dehydrogenase type 2 and 15-hydroxyprostaglandin dehydrogenase in human placenta of patients with preeclampsia. J Clin Endocrinol Metab 86:1313–1317.

Sha Q, Zhang S (2011) A test of Hardy-Weinberg equilibrium in structured populations. Genet Epidemiol 35:671-8

67

Singhal A, Lucas A. (2004) Early origins of cardiovascular disease: Is there a unifying hypothesis?. Lancet 363:1642–1645.

Skogen JC, Overland S (2012) The fetal origins of adult disease: a narrative review of the epidemiological literature. JRSM Short Rep 3:59

Smith CM, Wright NP, Wales JK, Mackenzie C, Primhak RA, Eastell R, Walsh JS (2011) Very low birth weight survivors have reduced peak bone mass and reduced insulin sensitivity. Clin Endocrinol (Oxf) 75:443-449.

Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS (1994) Estrogen resistance caused by a mutation in the estrogen-receptor gene in man. N Engl J Med 331:1056–1061

Suzuki M, Kanazawa A, Hasegawa M, Hattori Y, Harano Y. (1999) A close association between insulin resistance and dehydroepiandrosterone sulfate in subjects with essential hypertension. Endocr J 46:521-528.

Szathmári M (2001) A dehidroepiandroszteron és szulfát észterének anyagcsere hatásai. Akadémiai doktori értekezés, Budapest

Szathmári M, Szűcs J, Fehér T, Holló I (1994) Dehydroepiandrosterone sulphate and bone mineral density. Osteoporos Int 4:84–88

Szathmári M, Vásárhelyi B, Reusz GS, Tulassay T (2000) Adult cardiovascular risk factors in premature babies. Lancet 356:945– 946

Szathmári M, Vásárhelyi B, Szabó M, Szabó A, Reusz GS, Tulassay T (2000) Higher osteocalcin levels and cross-links excretion in young men born with low birth weight.

Calcified Tissue Int 67:429–433

Szathmári M, Vásárhelyi B, Tulassay T (2001) Effect of low birth weight on adrenal steroids and carbohydrate metabolism in early adulthood. Horm Res 55:172–178

Tamminen M, Kakko S, Kesaniemi YA, Savolainen MJ (1996) A polymorphic site in the 3' untranslated region of the cholesteryl ester transfer protein (CETP) gene is associated with low CETP activity. Atherosclerosis 124:237-247.

Thamer C, Koch M, Haap M, Machicao F, Haring HU, Stumvoll M (2002) Association of the ACE gene I/D polymorphism with insulin sensitivity depends on the

Thamer C, Koch M, Haap M, Machicao F, Haring HU, Stumvoll M (2002) Association of the ACE gene I/D polymorphism with insulin sensitivity depends on the